bibliographic resource 560043 [br/560043]
https://w3id.org/oc/corpus/br/560043

is a
title
  • Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
publication date
  • 2013-01-01
contributor
format
identifier
part of